Cargando…
The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China
BACKGROUND: Esophageal cancer (EC) often occurs in the elderly, and approximately 40% of patients are 70 years or older. To investigate the long‐term survival of EC in elderly patients, to provide a theoretical direction for better management and predicting survival of EC based on the hospital‐based...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972158/ https://www.ncbi.nlm.nih.gov/pubmed/36210795 http://dx.doi.org/10.1002/cam4.5307 |
_version_ | 1784898263474765824 |
---|---|
author | Li, Runhua He, Yutong Sun, Xibin Wang, Ning Zhang, Min Wei, Kuangrong Li, Huizhang Dong, Peng Du, Lingbin Chen, Wanqing |
author_facet | Li, Runhua He, Yutong Sun, Xibin Wang, Ning Zhang, Min Wei, Kuangrong Li, Huizhang Dong, Peng Du, Lingbin Chen, Wanqing |
author_sort | Li, Runhua |
collection | PubMed |
description | BACKGROUND: Esophageal cancer (EC) often occurs in the elderly, and approximately 40% of patients are 70 years or older. To investigate the long‐term survival of EC in elderly patients, to provide a theoretical direction for better management and predicting survival of EC based on the hospital‐based multi‐center study in China. METHODS: The study was conducted in 18 hospitals including 6 provincial hospitals, 8 municipal hospitals, and 4 county hospitals. We extracted information from medical record homepage, records of admission and discharge, and pathological diagnosis reports from the medical record department of the elderly patients at 70–84 years old to obtain the 3‐year and 5‐year overall survival (OS), and main associated factors, and to analyze the current therapeutic effect of different treatment options for elderly patients. RESULTS: The 3‐year and 5‐year OS rate of the 1013 elderly patients was 44.8% and 32.8%, respectively. Their median survival was 28.00 months. The median survival of patients with squamous cell carcinoma was longer than that of other pathological type (squamous vs. other types: 31.00 vs. 20.00 months, p = 0.018). The median survival of patients with surgery only or combined therapy was longer than that of radiotherapy, chemotherapy, and no therapy (surgery only vs. combined therapy vs. radiotherapy vs. chemotherapy vs. no therapy: 56.00 vs. 33.00 vs. 26.00 vs.18.00 vs. 16.00 months, p < 0.001). The 5‐year OS rate of patients with highly differentiated cancer was higher than that of medium differentiated and poor differentiation/undifferentiated. In multivariate analysis, the older ages, pathological stage, were independent prognostic risk factors for poor EC survival. Treatment method was independent protective factors predictive of a good EC OS. CONCLUSIONS: The survival rate of the elderly EC patients was still low in China. Age, therapy method, and pathological stage were mainly associated with the survival rate of EC in elderly patients. |
format | Online Article Text |
id | pubmed-9972158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99721582023-03-01 The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China Li, Runhua He, Yutong Sun, Xibin Wang, Ning Zhang, Min Wei, Kuangrong Li, Huizhang Dong, Peng Du, Lingbin Chen, Wanqing Cancer Med RESEARCH ARTICLES BACKGROUND: Esophageal cancer (EC) often occurs in the elderly, and approximately 40% of patients are 70 years or older. To investigate the long‐term survival of EC in elderly patients, to provide a theoretical direction for better management and predicting survival of EC based on the hospital‐based multi‐center study in China. METHODS: The study was conducted in 18 hospitals including 6 provincial hospitals, 8 municipal hospitals, and 4 county hospitals. We extracted information from medical record homepage, records of admission and discharge, and pathological diagnosis reports from the medical record department of the elderly patients at 70–84 years old to obtain the 3‐year and 5‐year overall survival (OS), and main associated factors, and to analyze the current therapeutic effect of different treatment options for elderly patients. RESULTS: The 3‐year and 5‐year OS rate of the 1013 elderly patients was 44.8% and 32.8%, respectively. Their median survival was 28.00 months. The median survival of patients with squamous cell carcinoma was longer than that of other pathological type (squamous vs. other types: 31.00 vs. 20.00 months, p = 0.018). The median survival of patients with surgery only or combined therapy was longer than that of radiotherapy, chemotherapy, and no therapy (surgery only vs. combined therapy vs. radiotherapy vs. chemotherapy vs. no therapy: 56.00 vs. 33.00 vs. 26.00 vs.18.00 vs. 16.00 months, p < 0.001). The 5‐year OS rate of patients with highly differentiated cancer was higher than that of medium differentiated and poor differentiation/undifferentiated. In multivariate analysis, the older ages, pathological stage, were independent prognostic risk factors for poor EC survival. Treatment method was independent protective factors predictive of a good EC OS. CONCLUSIONS: The survival rate of the elderly EC patients was still low in China. Age, therapy method, and pathological stage were mainly associated with the survival rate of EC in elderly patients. John Wiley and Sons Inc. 2022-10-10 /pmc/articles/PMC9972158/ /pubmed/36210795 http://dx.doi.org/10.1002/cam4.5307 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | RESEARCH ARTICLES Li, Runhua He, Yutong Sun, Xibin Wang, Ning Zhang, Min Wei, Kuangrong Li, Huizhang Dong, Peng Du, Lingbin Chen, Wanqing The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China |
title | The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China |
title_full | The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China |
title_fullStr | The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China |
title_full_unstemmed | The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China |
title_short | The long‐term survival of esophageal cancer in elderly patients: A multi‐center, retrospective study from China |
title_sort | long‐term survival of esophageal cancer in elderly patients: a multi‐center, retrospective study from china |
topic | RESEARCH ARTICLES |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972158/ https://www.ncbi.nlm.nih.gov/pubmed/36210795 http://dx.doi.org/10.1002/cam4.5307 |
work_keys_str_mv | AT lirunhua thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT heyutong thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT sunxibin thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT wangning thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT zhangmin thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT weikuangrong thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT lihuizhang thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT dongpeng thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT dulingbin thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT chenwanqing thelongtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT lirunhua longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT heyutong longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT sunxibin longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT wangning longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT zhangmin longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT weikuangrong longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT lihuizhang longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT dongpeng longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT dulingbin longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina AT chenwanqing longtermsurvivalofesophagealcancerinelderlypatientsamulticenterretrospectivestudyfromchina |